Catalyst Wire Dossier Catalyst Wire Dossier

Licensed Meningococcal Serogroup C Conjugate Vaccine

Neisseria meningitidis serogroup C meningococcal conjugate vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Licensed Meningococcal Serogroup C Conjugate Vaccine, covering 2012-07-23 to 2012-07-23. Get the full timeline:

Most recent: Clinical Trial Update: 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age [Phase 2]

See pricing